Home > Financial Ratios > WINDLAS BIOTECH

WINDLAS BIOTECH
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 19.5611.296.365.920.11

What is the latest EV/Core EBITDA ratio of WINDLAS BIOTECH ?

The latest EV/Core EBITDA ratio of WINDLAS BIOTECH is 19.56 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202519.56
Mar202411.29
Mar20236.36
Mar20225.92
Mar20210.11

How is EV/Core EBITDA of WINDLAS BIOTECH Trending?

Years EV/Core EBITDA % Change
Mar2025 19.56
73.25
Mar2024 11.29
77.52
Mar2023 6.36
7.43
Mar2022 5.92
5,281.82
Mar2021 0.11 -

Other Financial Ratios of WINDLAS BIOTECH


Compare EV/Core EBITDA ratio of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,694.1 Cr 3.1% -4.6% -17.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,610.0 Cr -2.1% 13.6% 6.3% Stock Analytics
DIVIS LABORATORIES ₹179,279.0 Cr -2% 6.2% 3.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,649.0 Cr 0.5% 8.2% 39% Stock Analytics
CIPLA ₹114,469.0 Cr 1.3% 9.5% -4.6% Stock Analytics
DR REDDYS LABORATORIES ₹110,955.0 Cr 0.6% 1% 8.8% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

3.1%

-4.6%

-17.8%

SENSEX

1.1%

-2.1%

-6.4%


You may also like the below Video Courses